explore -WSS

explore

author：entertainment 2025-08-27 16:47:22 - browse：41

Novo Nordisk headquarters -- health coverage from STAT — Novo Nordisk's headquarters, outside Copenhagen, Denmark. LISELOTTE SABROE/Scanpix/AFP via Getty Images

Novo Nordisk is pausing ads for its obesity drug Wegovy as it struggles to keep up with surging demand, the latest hurdle in its rollout of the weight loss drug.

“To avoid stimulating further demand for this medicine, we’re pausing some key Wegovy promotional efforts,” the Danish drugmaker said in an emailed statement. “We are pausing all local television advertising and postponing planned national television advertising for Wegovy. We are also assessing our promotional efforts to healthcare professionals and adjusting accordingly.” The news was earlier reported by Endpoints.

Wegovy, which contains the active ingredient semaglutide, has become immensely popular for its effectiveness in helping people lose weight and is helping usher in what many see as a sea change in obesity treatment. Its sister drug for diabetes, Ozempic, has also been in demand for a similar effect on weight loss.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Trump demands the U.S. pay no more for drugs than other countries … again
Next article： As Taiwan prepares for anti

WSS

As Taiwan prepares for anti

Artificial intelligence advances fuel industry trying to preserve loved ones after death

Anxious about a speech? A startup wants you to pop a minty cardiac drug

NVIDIA and Google execs on the future of AI and drug discovery

New rules on organ donation and transplantation 'will bring chaos'

How a billionaire couple greased the skids for Pelosi’s drug pricing bill

knowledge

explore

hotspot

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Addiction experts warn against a second 'war on drugs'

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Caitlin Bernard's story shows physicians can't shy from advocacy

Wildfire smoke exposes gaps in outdoor worker protections

The Readout: Lisata, Eisai x Biogen, and the Met Gala (!)

Jerome Adams on the need for new antivirals for Covid

In new study, freeze

Bright Health sells Medicare Advantage business to Molina

Providers still hesitate to prescribe buprenorphine, study finds

leisure time

Second House panel advances two

Addiction experts warn against a second 'war on drugs'

It's time to retire 'poor historian' from clinicians' vocabularies

Microsoft's Peter Lee says ChatGPT shouldn't be used for initial diagnosis

Our daughter's deadly disease: trisomy 18. We wanted to protect her

Readers respond to H5N1 and livestock movements, and more

hotspot

hotspot

Wikipedia

entertainment